The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Cell-Based Therapeutics: The Next Pillar of Medicine
Open accessAbstract
Biomedicine sits on the cusp of a new revolution: the use of microbial and human cells as versatile therapeutic engines.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
RNA-Guided Human Genome Engineering via Cas9
Mali, P., Yang, L., Esvelt, K. M., Aach, J., Guell, M., DiCarlo, J. E., Norville, J. E., & Church, G. M. (2013) · Science · doi:10.1126/science.1232033 · Cited by 9,210
Improved survival with vemurafenib in melanoma with BRAF V600E mutation
Chapman, P. B., Hauschild, A., Robert, C., Haanen, J. B., Ascierto, P., Larkin, J., Dummer, R., Garbe, C., Testori, A., Maio, M., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1103782 · Cited by 7,720
Paclitaxel–Carboplatin Alone or with Bevacizumab for Non–Small-Cell Lung Cancer
Sandler, A., Gray, R., Perry, M. C., Brahmer, J., Schiller, J. H., Dowlati, A., Lilenbaum, R., & Johnson, D. H. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa061884 · Cited by 5,761
Duodenal Infusion of Donor Feces for Recurrent Clostridium difficile
van Nood, E., Vrieze, A., Nieuwdorp, M., Fuentes, S., Zoetendal, E. G., de Vos, W. M., Visser, C. E., Kuijper, E. J., Bartelsman, J. F. W. M., Tijssen, J. G. P., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1205037 · Cited by 3,708
Chimeric antigen receptor–modified T cells in chronic lymphoid leukemia
Porter, D. L., Levine, B. L., Kalos, M., Bagg, A., & June, C. H. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1103849 · Cited by 3,565
Kalos, M., Levine, B. L., Porter, D. L., Katz, S., Grupp, S. A., Bagg, A., & June, C. H. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3002842 · Cited by 2,388
A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency
Hacein-Bey-Abina, S., von Kalle, C., Schmidt, M., Le Deist, F., Wulffraat, N., McIntyre, E., Radford, I., Villeval, J.-L., Fraser, C. C., Cavazzana-Calvo, M., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejm200301163480314 · Cited by 1,867 · cited 1×
“On one hand, a primary safety concern for mammalian cell-based therapeutics is that the cells will become transformed and divide uncontrollably, forming a circulating cancer or a solid tumor (20).”
BackgroundAdoptive immunotherapy for cancer: harnessing the T cell response
Restifo, N. P., Dudley, M. E., & Rosenberg, S. A. (2012) · Nature Reviews Immunology · doi:10.1038/nri3191 · Cited by 1,688
Inducible Apoptosis as a Safety Switch for Adoptive Cell Therapy
Di Stasi, A., Tey, S.-K., Dotti, G., Fujita, Y., Kennedy-Nasser, A., Martinez, C., Straathof, K., Liu, E., Durett, A. G., Grilley, B., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1106152 · Cited by 1,512
Schwartz, R. H. (2003) · Annual Review of Immunology · doi:10.1146/annurev.immunol.21.120601.141110 · Cited by 1,487
Hematopoietic Stem Cell Quiescence Maintained by p21 cip1/waf1
Cheng, T., Rodrigues, N., Shen, H., Yang, Y.-G., Dombkowski, D., Sykes, M., & Scadden, D. T. (2000) · Science · doi:10.1126/science.287.5459.1804 · Cited by 1,339
Brunstein, C. G., Miller, J. S., Cao, Q., McKenna, D. H., Hippen, K. L., Curtsinger, J., DeFor, T., Levine, B. L., June, C. H., Rubinstein, P., et al. (2011) · Blood · doi:10.1182/blood-2010-07-293795 · Cited by 1,045
Spatiotemporal control of cell signalling using a light-switchable protein interaction
Levskaya, A., Weiner, O. D., Lim, W. A., & Voigt, C. A. (2009) · Nature · doi:10.1038/nature08446 · Cited by 1,009
Self-citationEffect of genetic variation in the organic cation transporter 1 (OCT1) on metformin action
Shu, Y., Sheardown, S. A., Brown, C., Owen, R. P., Zhang, S., Castro, R. A., Ianculescu, A. G., Yue, L., Lo, J. C., Burchard, E. G., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30558 · Cited by 967
Petrof, E. O., Gloor, G. B., Vanner, S. J., Weese, S. J., Carter, D., Daigneault, M. C., Brown, E. M., Schroeter, K., & Allen-Vercoe, E. (2013) · Microbiome · doi:10.1186/2049-2618-1-3 · Cited by 731
Synthetic Gene Networks That Count
Friedland, A. E., Lu, T. K., Wang, X., Shi, D., Church, G., & Collins, J. J. (2009) · Science · doi:10.1126/science.1172005 · Cited by 587
Microbiota-Targeted Therapies: An Ecological Perspective
Lemon, K. P., Armitage, G. C., Relman, D. A., & Fischbach, M. A. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3004183 · Cited by 286
Self-citationDesigning customized cell signalling circuits
Lim, W. A. (2010) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2904 · Cited by 257
Self-citationTherapeutic Modulation of Microbiota-Host Metabolic Interactions
Holmes, E., Kinross, J., Gibson, G. R., Burcelin, R., Jia, W., Pettersson, S., & Nicholson, J. K. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3004244 · Cited by 236
Cell Therapy Industry: Billion Dollar Global Business with Unlimited Potential
Mason, C., Brindley, D. A., Culme-Seymour, E. J., & Davie, N. L. (2011) · Regenerative Medicine · doi:10.2217/rme.11.28 · Cited by 152
Human Neural Stem Cells Induce Functional Myelination in Mice with Severe Dysmyelination
Uchida, N., Chen, K., Dohse, M., Hansen, K., Dean, J. M., Buser, J. R., Riddle, A., Beardsley, D. J., Wan, Y., Gong, X., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3004371 · Cited by 138
Community Health Care: Therapeutic Opportunities in the Human Microbiome
Sonnenburg, J. L., & Fischbach, M. A. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3001626 · Cited by 102
Self-citationPluripotent Stem Cell–Based Cancer Therapy: Promise and Challenges
Sharkis, S. J., Jones, R. J., Civin, C. I., & Jang, Y.-Y. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003920 · Cited by 81
A Decade of Cell Therapy Clinical Trials (2000–2010)
Culme-Seymour, E. J., Davie, N. L., Brindley, D. A., Edwards‐Parton, S., & Mason, C. (2012) · Regenerative Medicine · doi:10.2217/rme.12.45 · Cited by 67
FDA Oversight of Cell Therapy Clinical Trials
Au, P., Hursh, D. A., Lim, A., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3004131 · Cited by 39
Stem Cell Therapies Could Change Medicine… If They Get the Chance
Weissman, I. L. (2012) · Cell stem cell · doi:10.1016/j.stem.2012.05.014 · Cited by 33
Cited by
Designing hydrogels for controlled drug delivery
Li, J., & Mooney, D. J. (2016) · Nature Reviews Materials · doi:10.1038/natrevmats.2016.71 · Cited by 4,832
The Treatment-Naive Microbiome in New-Onset Crohn’s Disease
Gevers, D., Kugathasan, S., Denson, L. A., Vázquez-Baeza, Y., Van Treuren, W., Ren, B., Schwager, E., Knights, D., Song, S. J., Yassour, M., et al. (2014) · Cell Host & Microbe · doi:10.1016/j.chom.2014.02.005 · Cited by 3,220
The Microbiome in Inflammatory Bowel Disease: Current Status and the Future Ahead
Kostic, A. D., Xavier, R. J., & Gevers, D. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.02.009 · Cited by 1,789
The Principles of Engineering Immune Cells to Treat Cancer
Lim, W. A., & June, C. H. (2017) · Cell · doi:10.1016/j.cell.2017.01.016 · Cited by 1,080
Self-citationEngineering Customized Cell Sensing and Response Behaviors Using Synthetic Notch Receptors
Morsut, L., Roybal, K. T., Xiong, X., Gordley, R. M., Coyle, S. M., Thomson, M., & Lim, W. A. (2016) · Cell · doi:10.1016/j.cell.2016.01.012 · Cited by 1,000
Self-citation
Metadata
- Authors
- Fischbach, M. A., Bluestone, J. A., & Lim, W. A.
- Venue
- Science Translational Medicine
- Published
- 2013-04-03
- Volume
- 5
- Issue
- 179
- Pages
- 179ps7-179ps7
- ISSN
- 1946-6234 (ISSN-L)
- 1946-6242
- OpenAlex
- W2133897272
- Cited by
- 419
- References
- 26
- FWCI
- 20.08
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.